Related Experiment Video
Updated: Jun 9, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Omics research in atherosclerosis
Kai-Jiang Tian1,2, Yu Yang2, Guo-Shuai Chen3
1Pathology Department, The First Affiliated Hospital of Hebei North University, Zhangjiakou, 075000, China.
Insights
Atherosclerosis (AS), a chronic inflammatory disease, lacks effective treatments. Omics technologies offer new insights into AS mechanisms and potential therapeutic targets for cardiovascular diseases.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pathophysiology
Background:
- Atherosclerosis (AS) is a chronic inflammatory condition underlying cardiovascular diseases, marked by arterial intima lipid deposition, fibrous tissue proliferation, and calcification.
- The complex pathogenesis of AS, involving oxidative stress, inflammation, and lipid changes, remains incompletely understood.
- Current prevention and treatment strategies for AS are limited, highlighting the need for novel approaches.
Purpose of the Study:
- To review the application and impact of omics technologies in atherosclerosis research over the past decade.
- To identify the current status, challenges, limitations, and future prospects of omics in understanding AS.
- To highlight potential therapeutic targets for AS-related diseases identified through omics approaches.
Main Methods:
- Systematic review of research articles published in the last 10 years focusing on omics technologies and atherosclerosis.
- Analysis of genomic, transcriptomic, proteomic, and metabolomic studies related to AS.
- Evaluation of the clinical relevance and translational potential of omics findings in AS.
Main Results:
- Omics technologies (genomics, transcriptomics, proteomics, metabolomics) provide powerful tools for dissecting AS complexity.
- Significant advancements have been made in identifying molecular pathways and biomarkers associated with AS.
- Challenges remain in data integration, validation, and clinical translation of omics discoveries.
Conclusions:
- Omics technologies are revolutionizing atherosclerosis research, offering deeper insights into its pathophysiology.
- Further research is needed to overcome current limitations and translate omics findings into effective clinical applications.
- Targeting pathways identified through omics holds promise for developing novel therapeutic strategies for AS and related cardiovascular diseases.
Abstract:
Atherosclerosis (AS) is a chronic inflammatory disease characterized by lipid deposition within the arterial intima, as well as fibrous tissue proliferation and calcification. AS has long been recognized as one of the primary pathological foundations of cardiovascular diseases in humans. Its pathogenesis is intricate and not yet fully elucidated. Studies have shown that AS is associated with oxidative stress, inflammatory response, lipid deposition, and changes in cell phenotype. Unfortunately, there is currently no effective prevention or targeted treatment for AS. The rapid advancement of omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, has opened up novel avenues to elucidate the fundamental pathophysiology and associated mechanisms of AS. Here, we review articles published over the past decade and focus on the current status, challenges, limitations, and prospects of omics in AS research and clinical practice. Emphasizing potential targets based on omics technologies will improve our understanding of this pathological condition and assist in the development of potential therapeutic approaches for AS-related diseases.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical manifestations and prevention
Coronary Artery Disease I: Introduction
Atherosclerosis IV: Nursing Management
Coronary Artery Disease II: Pathophysiology

